PTH2R and osteoporosis: The parathyroid hormone receptors constitute one such example: a bioactive N-terminal fragment of parathyroid hormone (PTH, residues 1–34), used under the name teriparatide to treat osteoporosis, potently activates both type-1 and type-2 PTH-receptors (PTHR1/PTHR2)8.